The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening.
about
Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesisMendelian randomization study of B-type natriuretic peptide and type 2 diabetes: evidence of causal association from population studiesNatriuretic Peptide testing in primary careRacial differences in incident heart failure among young adults.Screening and Treatment for Subclinical Hypertensive Heart Disease in Emergency Department Patients With Uncontrolled Blood Pressure: A Cost-effectiveness Analysis.Evidence based diagnosticsNatriuretic Peptides and Assessment of Cardiovascular Disease Risk in Asymptomatic Persons.Blood signature of pre-heart failure: a microarrays study.Comparison of characteristics and outcomes of asymptomatic versus symptomatic left ventricular dysfunction in subjects 65 years old or older (from the Cardiovascular Health Study)Left ventricular dysfunction as a risk factor for cardiovascular and noncardiovascular hospitalizations in African AmericansCognitive behavioral therapy in depressed cardiac surgery patients: role of ejection fraction.Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation.Left ventricular dilation and incident congestive heart failure in asymptomatic adults without cardiovascular disease: multi-ethnic study of atherosclerosis (MESA).Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.Echocardiography, natriuretic peptides, and risk for incident heart failure in older adults: the Cardiovascular Health Study.Management of chronic heart failure: Role of home echocardiography in monitoring care programsAll patients older than age 60 years should not undergo a B-type natriuretic peptide screening test.Lean body mass index prognostic value for cardiovascular events in patients with coronary artery disease.Incident heart failure in relation to vascular disease: insights from the Health, Aging, and Body Composition Study.Screening for ventricular remodeling.Prognosis of individuals with asymptomatic left ventricular systolic dysfunction in the multi-ethnic study of atherosclerosis (MESA).Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers.B-type natriuretic peptide: a critical review.Burden of Systolic and Diastolic Left Ventricular Dysfunction Among Hispanics in the United States: Insights From the Echocardiographic Study of Latinos.Left atrial remodelling contributes to the progression of asymptomatic left ventricular systolic dysfunction to chronic symptomatic heart failure.Obesity cardiomyopathy: diagnosis and therapeutic implications.Predicting Heart Failure With Preserved and Reduced Ejection Fraction: The International Collaboration on Heart Failure SubtypesPredictors of new-onset heart failure: differences in preserved versus reduced ejection fractionContemporary strategies in the diagnosis and management of heart failureLeft ventricular systolic dysfunction and the risk of ischemic stroke in a multiethnic populationAmino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein as predictors of sudden cardiac death among women.Risk factors for asymptomatic ventricular dysfunction in rheumatoid arthritis patients.Association of novel biomarkers of cardiovascular stress with left ventricular hypertrophy and dysfunction: implications for screening.Nuclear cardiology and heart failure.Heart failure in hypertension: prevention and treatment.The Effect of Right Ventricular Apical and Nonapical Pacing on the Short- and Long-Term Changes in Left Ventricular Ejection Fraction: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials.Candidate biomarkers in heart failure with reduced and preserved ejection fraction.Red cell distribution width (RDW) correlates with markers of diastolic dysfunction in patients with impaired left ventricular systolic function.Screening echocardiograms in a senior focused value based primary care improves systolic heart failure detection and clinical management.Left ventricular area on non-contrast cardiac computed tomography as a predictor of incident heart failure - The Multi-Ethnic Study of Atherosclerosis.
P2860
Q24812557-E46B5426-81AC-443A-9F5C-7C6BFDCE6759Q28743489-80E148A7-5E53-4272-990F-B6484ACDA474Q33572286-2AF986B4-B75F-48FC-903D-F0D83F82EECDQ33692727-9C8F217B-31A4-4CAE-8EAA-CB7C61DA1C43Q33708076-B684E347-C434-4E81-8441-59712D1C8079Q33934950-269255C6-7F37-44C5-B1F1-4ABF6640416AQ33948944-A1048693-6648-4F74-A7FD-F9A9805E4723Q33952087-6C893CA0-8E00-46EB-A9F4-C929E9BCB817Q34084299-1415F542-8FBB-44BE-B72C-EF16C2A79D1DQ34125692-399ABE00-53C7-4C1F-807D-C3BCF6D18884Q34395280-E433F5A0-54E4-4FC8-B8D5-5FDA2FF1A31BQ34421298-DAC2A413-9763-4217-8F5D-E4971B3D08FDQ34603562-C55D0594-BF0C-49C2-BBEA-451F0CF87B39Q35797623-4B1F51F6-98B2-4B7B-81CC-932D05A92AA8Q35802753-FDCC0F34-7B8D-461E-AAA3-AC3A9CA29945Q35852500-805F764A-47F9-47C9-9148-B83C287415D1Q35987037-F1373687-E180-4EB3-9826-3D171F9FC01DQ36025033-D8CED036-9418-4953-843B-8EBE4FBC1001Q36288050-1CC667A2-4D2C-4439-A575-50BCDEBF6803Q36473364-E38F4A12-9386-47DC-9BFA-54D53BD88E2FQ36497087-6F4DFC58-5DC5-4026-A91B-A8328DBA75E3Q36716456-C84BB715-6221-4EA3-925E-4D1D535CF10BQ36724549-DB094FCE-BA4C-4C0A-B3CD-47F622326BACQ36784206-772100EC-09D0-47CB-B586-082A9CEB2F78Q36798364-AE515CCC-D19B-4B15-BE2F-F02CA9B4A72AQ36915912-04F4CFC5-6D03-4D68-BEDC-01C392DE1A34Q36992652-EBFC823C-B836-40B4-B18F-8D74E5FCF2AFQ36993734-B094959D-B286-4AA1-A7D7-0A6320A04152Q37041145-CF668F1D-82A7-4812-990E-8BE1C693EE7DQ37179200-D485A730-0D5C-4E50-983A-C15D9DEC030BQ37374009-C2A944DE-8E74-43CF-8BE2-D50BFE266739Q37400763-8FD0E2DB-E10B-412C-AABD-1A71425D656EQ37457712-30D3615A-E4BD-471C-8D2B-DCE7920ECC6FQ37578330-D958F483-4B27-4A44-A3E6-0BE6474E357DQ38022713-14CC62CE-65B1-4C58-BCC1-8E15B35281E0Q38533907-78635B90-2289-40AE-B6BB-C7AE55AB8413Q38572500-8946371B-51CC-44F2-968D-EFFBBC5D5E1FQ38724963-F90E5A08-128D-4579-911F-C1898D479376Q38752308-D9A7AB8A-903A-483D-8F83-E95329F91F03Q40631762-B7C198E3-D7C8-4EB3-BBA8-6BE6E3A0B0A0
P2860
The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
The epidemiology of "asymptoma ...... n: implications for screening.
@ast
The epidemiology of "asymptoma ...... n: implications for screening.
@en
type
label
The epidemiology of "asymptoma ...... n: implications for screening.
@ast
The epidemiology of "asymptoma ...... n: implications for screening.
@en
prefLabel
The epidemiology of "asymptoma ...... n: implications for screening.
@ast
The epidemiology of "asymptoma ...... n: implications for screening.
@en
P1476
The epidemiology of "asymptoma ...... n: implications for screening.
@en
P2093
Daniel Levy
Thomas J Wang
P304
P356
10.7326/0003-4819-138-11-200306030-00012
P407
P577
2003-06-01T00:00:00Z